1238 related articles for article (PubMed ID: 25999708)
21. Inverse relationship between nonadherence to original GOLD treatment guidelines and exacerbations of COPD.
Foda HD; Brehm A; Goldsteen K; Edelman NH
Int J Chron Obstruct Pulmon Dis; 2017; 12():209-214. PubMed ID: 28123293
[TBL] [Abstract][Full Text] [Related]
22. Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD.
Rhee CK; Kim JW; Hwang YI; Lee JH; Jung KS; Lee MG; Yoo KH; Lee SH; Shin KC; Yoon HK
Int J Chron Obstruct Pulmon Dis; 2015; 10():1623-31. PubMed ID: 26316736
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of undiagnosed airflow obstruction among people with a history of smoking in a primary care setting.
Fu SN; Yu WC; Wong CK; Lam MC
Int J Chron Obstruct Pulmon Dis; 2016; 11():2391-2399. PubMed ID: 27729780
[TBL] [Abstract][Full Text] [Related]
24. The effect of comorbidities on COPD assessment: a pilot study.
Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
[TBL] [Abstract][Full Text] [Related]
25. A score to predict short-term risk of COPD exacerbations (SCOPEX).
Make BJ; Eriksson G; Calverley PM; Jenkins CR; Postma DS; Peterson S; Östlund O; Anzueto A
Int J Chron Obstruct Pulmon Dis; 2015; 10():201-9. PubMed ID: 25670896
[TBL] [Abstract][Full Text] [Related]
26. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
[TBL] [Abstract][Full Text] [Related]
27. Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care.
Punekar YS; Landis SH; Wurst K; Le H
Respir Res; 2015 Nov; 16():141. PubMed ID: 26572740
[TBL] [Abstract][Full Text] [Related]
28. Health Care Resource Utilization and Exacerbation Rates in Patients with COPD Stratified by Disease Severity in a Commercially Insured Population.
Wallace AE; Kaila S; Bayer V; Shaikh A; Shinde MU; Willey VJ; Napier MB; Singer JR
J Manag Care Spec Pharm; 2019 Feb; 25(2):205-217. PubMed ID: 30698096
[TBL] [Abstract][Full Text] [Related]
29. Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets.
Jones RC; Price D; Chavannes NH; Lee AJ; Hyland ME; Ställberg B; Lisspers K; Sundh J; van der Molen T; Tsiligianni I;
NPJ Prim Care Respir Med; 2016 Apr; 26():16010. PubMed ID: 27053297
[TBL] [Abstract][Full Text] [Related]
30. COPD management costs according to the frequency of COPD exacerbations in UK primary care.
Punekar YS; Shukla A; Müllerova H
Int J Chron Obstruct Pulmon Dis; 2014; 9():65-73. PubMed ID: 24426781
[TBL] [Abstract][Full Text] [Related]
31. Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD.
Ke X; Marvel J; Yu TC; Wertz D; Geremakis C; Wang L; Stephenson JJ; Mannino DM
Int J Chron Obstruct Pulmon Dis; 2016; 11():1689-703. PubMed ID: 27555759
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of COPD patients according to GOLD classification and clinical phenotypes in the Russian Federation: the SUPPORT trial.
Arkhipov V; Arkhipova D; Miravitlles M; Lazarev A; Stukalina E
Int J Chron Obstruct Pulmon Dis; 2017; 12():3255-3262. PubMed ID: 29138554
[TBL] [Abstract][Full Text] [Related]
33. Comorbidity in chronic obstructive pulmonary disease. Related to disease severity?
Echave-Sustaeta JM; Comeche Casanova L; Cosio BG; Soler-Cataluña JJ; Garcia-Lujan R; Ribera X
Int J Chron Obstruct Pulmon Dis; 2014; 9():1307-14. PubMed ID: 25429213
[TBL] [Abstract][Full Text] [Related]
34. Risk Factors Associated with a First Exacerbation Among Patients with COPD Classified as GOLD A and B in Routine Clinical Practice in the UK.
Rothnie KJ; Numbere B; Gelwicks S; Lu Y; Sharma R; Compton C; Ismaila AS; Quint JK
Int J Chron Obstruct Pulmon Dis; 2023; 18():2673-2685. PubMed ID: 38022832
[TBL] [Abstract][Full Text] [Related]
35. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
Kawamatawong T; Onnipa J; Suwatanapongched T
Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
[TBL] [Abstract][Full Text] [Related]
36. The association between objectively measured physical activity and morning symptoms in COPD.
van Buul AR; Kasteleyn MJ; Chavannes NH; Taube C
Int J Chron Obstruct Pulmon Dis; 2017; 12():2831-2840. PubMed ID: 29042764
[TBL] [Abstract][Full Text] [Related]
37. Differences in outcomes between GOLD groups in patients with COPD in the TIOSPIR(®) trial.
Dusser D; Wise RA; Dahl R; Anzueto A; Carter K; Fowler A; Calverley PM
Int J Chron Obstruct Pulmon Dis; 2016; 11():133-45. PubMed ID: 26855568
[TBL] [Abstract][Full Text] [Related]
38. Resource Use and Costs up to Two Years Post Diagnosis Among Newly Diagnosed COPD Patients in the UK Primary Care Setting: A Retrospective Cohort Study.
Punekar YS; Wurst K; Shukla A
COPD; 2015 Jun; 12(3):267-75. PubMed ID: 25093809
[TBL] [Abstract][Full Text] [Related]
39. Frequency and risk factors of COPD exacerbations and hospitalizations: a nationwide study in Greece (Greek Obstructive Lung Disease Epidemiology and health ecoNomics: GOLDEN study).
Alexopoulos EC; Malli F; Mitsiki E; Bania EG; Varounis C; Gourgoulianis KI
Int J Chron Obstruct Pulmon Dis; 2015; 10():2665-74. PubMed ID: 26715845
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and global initiative for chronic obstructive lung disease group distribution of chronic obstructive pulmonary disease detected by preoperative pulmonary function test.
Choi SM; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Kim YW; Han SK; Yoo CG
PLoS One; 2015; 10(1):e0115787. PubMed ID: 25625286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]